BEAT News Alert Cardionet (BEAT) 10.36 02/14/2015 10:43:22

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 11:43 AM

Cardionet (BEAT) 10.36 $BEAT

BioTelemetry, Inc. to Release Fourth Quarter 2014 Earnings Results on February 19, 2015
GlobeNewswire - Thu Feb 12, 6:07PM CST
BioTelemetry, Inc. (Nasdaq:BEAT) will release its fourth quarter 2014 earnings on Thursday, February 19, 2015 at 4:00 PM Eastern Time.
BEAT: 10.36 (+0.20)

Can Cerner (CERN) Surprise Earnings Estimates in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 3:31PM CST
Cerner Corp (CERN) is set to report its fourth-quarter 2014 financial numbers on Feb 10. In the last reported quarter, the company's earnings were in line with the Zacks Consensus Estimate.
ACT: 285.37 (+3.71), ALNY: 95.54 (+1.67), BEAT: 10.36 (+0.20), CERN: 70.98 (+1.15)

Covance Earnings in Line, LabCorp Merger Awaits Closure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 8:36AM CST
Covance (CVD) delivered a healthy performance in the quarter, breaking all prior records, specifically with fourth quarter adjusted net orders amounting to $823 million.
ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20), LH: 116.90 (+0.06), CVD: 107.08 (+0.05)

Abiomed: A Strong Buy on Impressive Q3, Estimate Revision - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 4:30PM CST
We believe that Abiomed Inc.'s (ABMD) strong third-quarter fiscal 2015 results, raised fiscal 2015 guidance and the recent FDA HDE approval for its Impella RP System are the primary factors justifying the upgrade.
ABMD: 60.39 (+0.46), BEAT: 10.36 (+0.20), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)

Medtel24, Inc. Files Arbitration against Biotelemetry (NASDAQ: BEAT) and Certain of Its Subsidiaries
PR Newswire - Mon Feb 02, 2:51PM CST
Medtel24, Inc. announced today that it filed a Demand for Arbitration with the American Arbitration Association against Biotelemetry, Inc. (f/k/a Cardionet, LLC/Inc.) (NASDAQ: BEAT) and several of its subsidiaries or affiliates. The Demand asserts several breach of a contract claims and related common law claims.
BEAT: 10.36 (+0.20)

PAREXEL International Q2 Earnings, Revenues Top Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 10:40AM CST
PAREXEL International Corp's (PRXL) second-quarter fiscal 2015 adjusted earnings of 69 cents per share surged nearly 35.3% year over year on expanding margins.
BGMD: 0.88 (unch), PRXL: 62.91 (-0.18), ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)

CardioNet Up 24.6% Since SmarTrend Uptrend Call (BEAT)
Comtex SmarTrend(R) - Wed Jan 28, 9:25AM CST
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on October 31st, 2014 at $8.26. In approximately 3 months, CardioNet has returned 24.58% as of today's recent price of $10.29.
BEAT: 10.36 (+0.20)

Uptrend Call Working As CardioNet Stock Rises 27.6% (BEAT)
Comtex SmarTrend(R) - Tue Jan 20, 5:08PM CST
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on October 31st, 2014 at $8.26. In approximately 3 months, CardioNet has returned 27.60% as of today's recent price of $10.54.
BEAT: 10.36 (+0.20)

Commit To Purchase BioTelemetry At $9, Earn 13.9% Annualized Using Options
StockOptionsChannel.com - Wed Jan 14, 10:38AM CST
Investors considering a purchase of BioTelemetry, Inc. stock, but cautious about paying the going market price of $10.91/share, might benefit from considering selling puts among the alternative strategies at their disposal.
BEAT: 10.36 (+0.20)

CardioNet Has Returned 35.6% Since SmarTrend Recommendation (BEAT)
Comtex SmarTrend(R) - Tue Jan 13, 11:13AM CST
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on October 31st, 2014 at $8.26. In approximately 2 months, CardioNet has returned 35.59% as of today's recent price of $11.20.
BEAT: 10.36 (+0.20)

BioTelemetry, Inc. (BEAT) Jumps: Stock Adds 6.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 8:32AM CST
BioTelemetry, Inc. (BEAT) was a big mover last session, as the company saw its shares rise more than 6% on the day.
ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)

4 Earnings Plays for Q4: Add These to Your Portfolio - Analyst Blog
Sweta Killa - Zacks Investment Research - Mon Jan 12, 9:41AM CST
These stocks make for a great play this earnings season amid huge level of volatility.
AA: 15.81 (+0.16), TUBE: 15.69 (+0.93), BEAT: 10.36 (+0.20), ALGT: 178.42 (-4.07), LG: 51.59 (-0.47)

Investors' Radars Failed to Catch BioTelemetry (BEAT), Has Yours? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 09, 7:34AM CST
One company that looks well positioned for a solid gain, but has been overlooked by investors lately, is BioTelemetry, the stock of which company has actually seen rising estimates over the past one month.
BEAT: 10.36 (+0.20)

BioTelemetry Raised to Strong Buy on Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 9:00AM CST
On Jan 6, 2014, Zacks Investment Research upgraded BioTelemetry, Inc. (BEAT) to a Zacks Rank #1 (Strong Buy)
BGMD: 0.88 (unch), CTRX: 53.24 (+0.65), ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)

How BioTelemetry (BEAT) Stock Stands Out in a Strong Industry - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 7:34AM CST
BioTelemetry in the Medical Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
BEAT: 10.36 (+0.20)

24.1% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Tue Jan 06, 10:20AM CST
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on October 31st, 2014 at $8.26. In approximately 2 months, CardioNet has returned 24.09% as of today's recent price of $10.25.
BEAT: 10.36 (+0.20)

10 Events That Will Reshape The Post-2014 World - New Year's Review 2015
Marc Liu - at Seeking Alpha - Fri Jan 02, 12:33AM CST

LMT: 196.95 (-0.53), UPL: 15.67 (+0.84), C: 51.20 (+0.31), UUPT: 29.68 (-0.04), GOOG: 549.01 (+6.08), PCLN: 1,103.37 (+11.42), NG: 3.96 (+0.03), GT: 25.91 (-0.30), BEAT: 10.36 (+0.20), EOG: 96.92 (+2.12), XCO: 2.52 (+0.20), AAL: 48.39 (+0.51), GM: 37.62 (-0.40), MMP: 80.41 (-0.86), EPD: 34.44 (+0.19), CBS: 59.83 (+2.06)

Shares of BEAT Up 21.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Dec 30, 9:33AM CST
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on October 31st, 2014 at $8.26. In approximately 2 months, CardioNet has returned 21.19% as of today's recent price of $10.01.
BEAT: 10.36 (+0.20)

Analysis of the North American Cardiac Monitoring Products and Services Markets
M2 - Mon Dec 29, 2:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/7plv9t/analysis_of_the) has announced the addition of the "Analysis of the North American Cardiac Monitoring Products and Services Markets " report to their offering. The cardiac monitoring market will benefit from healthcare delivery challenges by promoting advanced monitoring solutions that help providers reduce 30-day readmissions for cardiac-associated conditions. Interest in the remote patient monitoring space is altering portfolio approaches across products and services. Key Questions This Study Will Answer - What segments of cardiac monitoring products and services have the best opportunities for growth? - What influence will outcomes from ACA and healthcare system changes have on cardiac monitoring? What are the drivers and restraints of critical importance? - What is the recent M&A activity in the cardiac product and services markets? - Are existing competitors structured to meet provider-customer needs? How are strategies changing? - What are the key predictions about the future of the cardiac products and service markets? Key Topics Covered: 1. EXECUTIVE SUMMARY 2. MARKET OVERVIEW 3. COMPETITIVE PLAYBOOK 4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL CARDIAC MONITORING MARKET 5. FORECAST AND TRENDS-CARDIAC MONITORING PRODUCTS MARKET 6. FORECAST AND TRENDS-CARDIAC MONITORING SERVICES MARKET 7. COMPETITIVE ENVIRONMENT-CARDIAC MONITORING PRODUCTS MARKET 8. CARDIAC MONITORING PRODUCTS MARKET-SEGMENT BREAKDOWN: RESTING ECG PRODUCTS SEGMENT 9. STRESS ECG PRODUCTS SEGMENT 10. DATA MANAGEMENT SYSTEMS SEGMENT 11. HOLTER MONITOR SEGMENT 12. EVENT MONITORING PRODUCTS SEGMENT 13. CARDIAC MONITORING SERVICES MARKET-SEGMENT BREAKDOWN: RESTING ECG SERVICES SEGMENT 14. STRESS ECG SERVICES SEGMENT 15. HOLTER MONITORING SERVICES SEGMENT 16. IDTF HOLTER MONITORING SERVICES SUBSEGMENT 17. EVENT MONITORING SERVICES SEGMENT 18. IDTF EVENT MONITORING SERVICES SUBSEGMENT 19. PACEMAKER MONITORING SERVICES SEGMENT 20. REMOTE CARDIAC SERVICES-A TELEHEALTH MATRIXTM DISCUSSION 21. KEY COMPANIES TO WATCH 22. THE LAST WORD 23. APPENDIX Companies Mentioned: - BioTelemetry, Inc. - eCardio - LifeWatch - Philips Healthcare For more information visit http://www.researchandmarkets.com/research/7p...sis_of_the
BEAT: 10.36 (+0.20)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Leadership Amidst Rapid Growth Surge

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

AI-Powered Travel Transformation in Norway Revealed

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Cogent Communications' Q3 2026 Earnings Call Details

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

Marshall Goldman Expands Footprint with Marino Acquisition

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Wagner Logistics Gears Up for Major Expansion in Liberty

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Truck Drivers USA & Career Driver Unveil New Driver Agent

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

FCS Drives Key FDA Approvals in Cancer Treatment

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

JiMMYBAR! Unveils World's First Creatine Trail Mix

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Tessa AI: Revolutionizing Biomedical Research with AI

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...